Analysis of tumor samples indicated that ablation of PYK2 either in the BC cells (Figure 8H), in the TME (Figure 8I), or both in the BC and in the TME (Figure 8I) also reduced the expression of the examined proangiogenic factors. Here, PTK2B is linked to breast cancer.